Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Head & Neck 1

Conditions

Neoplasms 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Scleroderma, Localized 1Radiation Injuries 1Prostatic Neoplasms 1Popliteal Cyst 1Polycystic Ovary Syndrome 1Pneumonia 1Neurodermatitis 1Neoplasm, Residual 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Lichen Planus 1Leukemia, Hairy Cell 1Leukemia 1Keratoacanthoma 1Keloid 1Hemangioma 1Head and Neck Neoplasms 1Granuloma Annulare 1Dermoid Cyst 1Dendritic Cell Sarcoma, Interdigitating 1Cicatrix, Hypertrophic 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neoplasms × Adrenal Cortex Hormones × Clear all
NCT00848718 2019-11-12

MK-2206-003

Merck Sharp & Dohme LLC

Phase 1 Completed
77 enrolled 24 charts
Tumor-Agnostic

Neoplasms

NCT02410382 2019-05-14

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

University of Arizona

Phase 2 Terminated
79 enrolled
Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡